Marc Guiu

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Sphingosine-1-Phosphate Receptor 1 Promotes Ovarian Cancer Tumorsphere Proliferation and Metastasis.

Sphingosine-1-Phosphate Receptor 1 Promotes Ovarian Cancer Tumorsphere Proliferation and Metastasis.

Journal: International journal of cancer

Published: July 28, 2025

Correction: The PP2A regulator IER5L supports prostate cancer progression.

Correction: The PP2A regulator IER5L supports prostate cancer progression.

Journal: Cell death & disease

Published: July 22, 2025

A bioinformatics screen identifies TCF19 as an aggressiveness-sustaining gene in prostate cancer.

A bioinformatics screen identifies TCF19 as an aggressiveness-sustaining gene in prostate cancer.

Journal: Molecular oncology

Published: April 16, 2025

The PP2A regulator IER5L supports prostate cancer progression.

The PP2A regulator IER5L supports prostate cancer progression.

Journal: Cell death & disease

Published: December 21, 2023

MAF amplification licenses ERα through epigenetic remodelling to drive breast cancer metastasis.

MAF amplification licenses ERα through epigenetic remodelling to drive breast cancer metastasis.

Journal: Nature cell biology

Published: September 16, 2022

Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy.

Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy.

Journal: Nature communications

Published: January 25, 2022

Loss of microRNA-135b Enhances Bone Metastasis in Prostate Cancer and Predicts Aggressiveness in Human Prostate Samples.

Loss of microRNA-135b Enhances Bone Metastasis in Prostate Cancer and Predicts Aggressiveness in Human Prostate Samples.

Journal: Cancers

Published: November 21, 2021

Targeted immunotherapy against distinct cancer-associated fibroblasts overcomes treatment resistance in refractory HER2+ breast tumors.

Targeted immunotherapy against distinct cancer-associated fibroblasts overcomes treatment resistance in refractory HER2+ breast tumors.

Journal: Nature communications

Published: July 20, 2021

In Vivo Assessment of Metastatic Cell Potential in Prostate Cancer.

In Vivo Assessment of Metastatic Cell Potential in Prostate Cancer.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: March 20, 2021

ERK1/2 Signaling Induces Upregulation of ANGPT2 and CXCR4 to Mediate Liver Metastasis in Colon Cancer.

ERK1/2 Signaling Induces Upregulation of ANGPT2 and CXCR4 to Mediate Liver Metastasis in Colon Cancer.

Journal: Cancer research

Published: December 27, 2019

Genetic manipulation of LKB1 elicits lethal metastatic prostate cancer.

Genetic manipulation of LKB1 elicits lethal metastatic prostate cancer.

Journal: The Journal of experimental medicine

Published: September 23, 2019

Correction: The anti-metastatic activity of collagenase-2 in breast cancer cells is mediated by a signaling pathway involving decorin and miR-21.

Correction: The anti-metastatic activity of collagenase-2 in breast cancer cells is mediated by a signaling pathway involving decorin and miR-21.

Journal: Oncogene

Published: May 05, 2019

Showing 1-12 of 29

Last Updated: 09/26/2026